📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cannabidiol for behavior symptoms in Alzheimer's disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial. (2024)

First Author: Velayudhan L

Attributed to: King’s College London Confidence in Concept 2017 funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1017/s1041610224000516

PubMed Identifier: 38584388

Publication URI: http://europepmc.org/abstract/MED/38584388

Type: Journal Article/Review

Volume: 36

Parent Publication: International psychogeriatrics

Issue: 12

ISSN: 1041-6102